Real-world Delivery and Outcomes of Intravesical BCG for Non-muscle-invasive Bladder Cancer
{{output}}
Background/aim: Intravesical bacillus Calmette-Guérin (BCG) therapy remains the standard adjuvant treatment for high-risk non-muscle-invasive bladder cancer (NMIBC), yet real-world maintenance delivery is frequently incomplete. ... ...
